Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Biomarx Inc

+1 (208) 275-0011
Website

Advertisement

Advertisement

411 Massachusetts Ave
Cambridge, MA 02139
+1 (208) 275-0011
https://www.biomark.com

Biomarx Inc is a research and development company based in Cambridge, MA, specializing in innovative biotechnology solutions.

With a focus on cutting-edge technologies and scientific advancements, Biomarx Inc is dedicated to pushing the boundaries of biomedicine and improving human health.

Generated from their business information

Also at this address

Watermark Central Venture LLC

Photo by bostonp2021

Muku Ramen

tripadvisor logo
5 reviews

Inctank

Molysym Corp

Find related places

Contractors

Contractors

Own this business?
Claim it
See a problem?

You might also like

Momenta Pharmaceuticals
Business services, nec, nec, Services, nec, nec, Drugs and drug proprietaries

Momenta Pharmaceuticals

Alnylam Pharmaceuticals is a biopharmaceutical company. The company develops novel therapeutics based on the biological breakthrough known as ribonucleic acid interference. The company applies ribonucleic acid interference to address significant medical needs, many of which cannot effectively be addressed with small molecules or antibodies. This discovery enables the creation of a broad new class of human therapeutics. Alnylam Pharmaceuticals maintains partnerships with leading pharmaceutical and medical technology companies to drive further developments and capabilities. Major alliances include Merck, Medtronic and Novartis. Alnylam Pharmaceuticals, founded in 2002, maintains global headquarters in Cambridge, Mass., and has an additional operating unit in Kulmbach, Germany.
Nonresidential construction, nec, nec, Drugs affecting neoplasms and endrocrine systems

TheracosBio, LLC

TheracosBio is a biopharmaceutical company based in Marlborough, MA, dedicated to providing affordable medications for prevalent diseases. Their mission is to ensure access to new medications for patients with common conditions, believing that affordable pricing can improve public health outcomes. Led by a team of experienced professionals, including President and CEO Brian Connelly, TheracosBio is focused on marketing their FDA-approved medication, Brenzavvy bexagliflozin, which offers a critical and cost-effective option for patients with Type 2 Diabetes. With a leadership team that brings together expertise in business, law, finance, intellectual property, regulatory affairs, clinical operations, chemistry, manufacturing, quality assurance, and supply chain management, TheracosBio is well-positioned to deliver innovative therapeutic technologies. Their commitment to affordable medications and improved access to the latest treatments sets them apart in the industry, aiming to make a positive impact on public health.Generated from the website
Nonresidential construction, nec, nec

Molysym Corp

United States›Massachusetts›Cambridge›Biomarx Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell